Riskpilot← Back to searchSign inGet full accessHårlev Dyreklinik ApS
APSActiveCVR 41455322Faxevej 27BVeterinary activities · NACE 7500Est. 20205 employeeswww.haarlevdyreklinik.dk
Revenue 2025
DKK 3,5M
-1% vs 2024
EBITDA margin
23.6%
-32% vs 2024
Equity ratio
36.9%
Financial strength
Net profit 2025
DKK 354K
-56% vs 2024
| Revenue | DKK 3,5M | -1% |
| EBITDA | DKK 834K | -32% |
| Net profit | DKK 354K | -56% |
| Total assets | DKK 3,7M | +10% |
| Equity | DKK 1,4M | -44% |
| Employees | 5 | — |
Legal name
Hårlev Dyreklinik ApS
CVR number
41455322
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
15. juni 2020
Share capital
DKK 1.002.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Virksomhedens hovedformål er at drive virksomhed som dyrlæge, dyreklinik og hermed beslægtet virksomhed.
Address
Faxevej 27B
Phone
+4556286168
Email
info@haarlevdyreklinik.dk
Website
www.haarlevdyreklinik.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3.509 | 3.560 | 3.526 | 3.556 | 3.538 |
| Staff expenses | -1.721 | -1.796 | -1.947 | -2.331 | -2.704 |
| EBITDA | 1.788 | 1.763 | 1.579 | 1.225 | 834 |
| Depreciation & amort. | -297 | -301 | -301 | -301 | -311 |
| EBIT | 1.491 | 1.462 | 1.278 | 924 | 523 |
| Net financials | -155 | -53 | -21 | 104 | -68 |
| Profit before tax | 1.336 | 1.409 | 1.258 | 1.028 | 455 |
| Tax | 307 | 309 | 283 | 232 | 101 |
| Net profit | 1.029 | 1.100 | 974 | 796 | 354 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5.260 | 4.273 | 4.244 | 3.355 | 3.678 |
| Equity | 2.031 | 2.380 | 2.605 | 2.400 | 1.356 |
| Long-term debt | 1.772 | 793 | 750 | 0 | 0 |
| Short-term debt | 1.439 | 1.052 | 817 | 857 | 2.202 |
| Total debt | 3.211 | 1.845 | 1.567 | 857 | 2.202 |
EBITDA margin
23.6%
This company
15.8%
Market median
+49% vs market
20212025
Equity ratio
36.9%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
20212025
Net profit margin
10.0%
This company
8.1%
Market median
+23% vs market
20212025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-06-15 – 2021-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BØ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AK Management | Management | 2023 | — | — |
JL Management | Management | 2024 | — | — |
SK Management | Management | 2023 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JLWS Holding ApS | Company | 33.3% | 33.3% | 2024 |
Anne Katrine Jørgensen Holding ApS | Company | 33.3% | 33.3% | 2020 |
Signe Kildetoft Holding ApS | Company | 33.3% | 33.3% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anne Katrine Jørgensen Holding ApS
Hårlev Dyreklinik ApS Board members of Hårlev Dyreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjarne Østergaard Rasmussen | Chief Executive Officer | 0 companies |
| Anne Katrine Jørgensen | Management | 0 companies |
| Julie Lolk Wolff-Sneedorff | Management | 0 companies |
| Signe Kildetoft | Management | 0 companies |